Literature DB >> 33448673

Mitochondrial DNA-depleter mouse as a model to study human pigmentary skin disorders.

Kyrene M Villavicencio1, Noha Ahmed2,3, Melissa L Harris1, Keshav K Singh2.   

Abstract

Pigmentation abnormalities are reported in the spectrum of phenotypes associated with aging and in patients with mitochondrial DNA depletion syndrome (MDS). Yet, a relevant animal model that mimics these effects and would allow us to evaluate the detrimental aspects of mtDNA depletion on melanocyte function has not been described. Here, we characterize the pigmentary changes observed in the ears of a mtDNA-depleter mouse, which phenotypically includes accentuation of the peri-adnexal pseudonetwork, patchy hyper- and hypopigmentation, and reticular pigmentation. Histologically, these mice show increased epidermal pigmentation with patchy distribution, along with increased and highly dendritic melanocytes. These mtDNA-depleter mice mimic aspects of the cutaneous, pigmentary changes observed in humans with age-related senile lentigines as well as MDS. We suggest that this mouse model can serve as a novel resource for future interrogations of how mitochondrial dysfunction contributes to pigmentary skin disorders. The mtDNA-depleter mouse model also serves as a useful tool to identify novel agents capable of treating pigmentary changes associated with age-related mitochondrial dysfunction in humans.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  lentigines; melanocyte; mitochondria; mtDNA depletion; skin

Mesh:

Substances:

Year:  2020        PMID: 33448673      PMCID: PMC9375690          DOI: 10.1111/pcmr.12921

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.159


  45 in total

1.  The role of the epidermal endothelin cascade in the hyperpigmentation mechanism of lentigo senilis.

Authors:  S Kadono; I Manaka; M Kawashima; T Kobayashi; G Imokawa
Journal:  J Invest Dermatol       Date:  2001-04       Impact factor: 8.551

2.  Senile lentigo.

Authors:  C HODGSON
Journal:  Arch Dermatol       Date:  1963-02

3.  Mitochondrial dynamics regulate melanogenesis through proteasomal degradation of MITF via ROS-ERK activation.

Authors:  Eun Sung Kim; So Jung Park; Myeong-Jin Goh; Yong-Joo Na; Doo Sin Jo; Yoon Kyung Jo; Ji Hyun Shin; Eun Sun Choi; Hae-Kwang Lee; Ju-Yeon Kim; Hong Bae Jeon; Jin Cheon Kim; Dong-Hyung Cho
Journal:  Pigment Cell Melanoma Res       Date:  2014-08-27       Impact factor: 4.693

4.  Mitochondrial DNA deletions in human skin reflect photo- rather than chronologic aging.

Authors:  M A Birch-Machin; M Tindall; R Turner; F Haldane; J L Rees
Journal:  J Invest Dermatol       Date:  1998-02       Impact factor: 8.551

Review 5.  Mitochondrial dysfunction: a neglected component of skin diseases.

Authors:  René G Feichtinger; Wolfgang Sperl; Johann W Bauer; Barbara Kofler
Journal:  Exp Dermatol       Date:  2014-09       Impact factor: 3.960

6.  Characteristics of keratinocytes in facial solar lentigo with flattened rete ridges: comparison with melasma.

Authors:  J Shin; J-Y Park; S J Kim; H Y Kang
Journal:  Clin Exp Dermatol       Date:  2015-02-22       Impact factor: 3.470

7.  Photoageing-associated mitochondrial DNA length mutations in human skin.

Authors:  J H Yang; H C Lee; Y H Wei
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

8.  Atypical presentation of multisystem disorders in two girls with mitochondrial DNA deletions.

Authors:  M H Tulinius; A Oldfors; E Holme; N G Larsson; M Houshmand; P Fahleson; L Sigström; B Kristiansson
Journal:  Eur J Pediatr       Date:  1995-01       Impact factor: 3.183

9.  Age-Dependent Decrease of Mitochondrial Complex II Activity in Human Skin Fibroblasts.

Authors:  Amy Bowman; Mark A Birch-Machin
Journal:  J Invest Dermatol       Date:  2016-01-29       Impact factor: 8.551

10.  Murine cutaneous mastocytosis and epidermal melanocytosis induced by keratinocyte expression of transgenic stem cell factor.

Authors:  T Kunisada; S Z Lu; H Yoshida; S Nishikawa; S Nishikawa; M Mizoguchi; S Hayashi; L Tyrrell; D A Williams; X Wang; B J Longley
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.